Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magris Performance Materials is a leading producer of high-quality talc and industrial minerals, serving a wide range of industries including pharmaceuticals, personal care, and plastics. The company established its market leadership through the 2021 acquisition of the North American talc assets of Imerys. In the life sciences sector, Magris provides pharmaceutical-grade talc used as an excipient in tablet manufacturing, acting as a glidant and lubricant. The company operates several mines and processing facilities across North America, ensuring a stable supply chain for critical industrial and medical applications. Its products are essential for improving the flow and consistency of solid dosage forms in the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magris Performance Materials.